Exact Mass: 424.177827
Exact Mass Matches: 424.177827
Found 395 metabolites which its exact mass value is equals to given mass value 424.177827,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Clindamycin
C18H33ClN2O5S (424.17985980000003)
Clindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin inhibits bacterial protein synthesis by binding to bacterial 50S ribosomal subunits. It may be bacteriostatic or bactericidal depending on the organism and drug concentration. Clindamycin, also known as cleocin or 7-CDL, belongs to the class of organic compounds known as proline and derivatives. Proline and derivatives are compounds containing proline or a derivative thereof resulting from reaction of proline at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. Clindamycin is a drug. Clindamycin is a semisynthetic lincosamide antibiotic that has largely replaced lincomycin due to an improved side effect profile. Clindamycin is a very strong basic compound (based on its pKa). In humans, clindamycin is involved in clindamycin action pathway. Orally and parenterally administered clindamycin has been associated with severe colitis (pseudomembranous colitis) which may result in patient death. Use of the topical formulation of clindamycin results in absorption of the antibiotic from the skin surface. Clindamycin is a potentially toxic compound. Rapidly absorbed after oral administration with peak serum concentrations observed after about 45 minutes. Oral; topical; parenteral (intramuscular, intravenous). Systemic/vaginal clindamycin inhibits protein synthesis of bacteria by binding to the 50S ribosomal subunits of the bacteria. Clindamycin. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=18323-44-9 (retrieved 2024-06-28) (CAS RN: 18323-44-9). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
N,N'-diacetylchitobiose
C16H28N2O11 (424.16930179999997)
N,N-diacetylchitobiose, also known as (GlcNAc)2, is classified as a member of the Acylaminosugars. Acylaminosugars are organic compounds containing a sugar linked to a chain through N-acyl group. N,N-diacetylchitobiose is considered to be soluble (in water) and acidic. N,N-diacetylchitobiose may be a unique E.coli metabolite N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
Trimethobenzamide hydrochloride
C21H29ClN2O5 (424.17648940000004)
D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents Trimethobenzamide hydrochloride is a blocker of the D2 receptor. Trimethobenzamide is an antiemetic used to prevent nausea and vomiting.
Taraxinic acid glucosyl ester
Constituent of Taraxacum officinale (dandelion). Taraxinic acid glucosyl ester is found in many foods, some of which are coffee and coffee products, dandelion, tea, and alcoholic beverages. Taraxinic acid glucosyl ester is found in alcoholic beverages. Taraxinic acid glucosyl ester is a constituent of Taraxacum officinale (dandelion).
8-Acetylneosolaniol
Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-fluoro-2-(2-pyrimidinyl)phenyl)-
Forsmann antigen
C16H28N2O11 (424.16930179999997)
Galnac-1-4-glcnac
C16H28N2O11 (424.16930179999997)
Lacdinac
C16H28N2O11 (424.16930179999997)
N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
SPIRADOLINE
C22H30Cl2N2O2 (424.16842199999996)
Crepidiaside B
Crepidiaside b is a member of the class of compounds known as O-glycosyl compounds. O-glycosyl compounds are glycoside in which a sugar group is bonded through one carbon to another group via a O-glycosidic bond. Crepidiaside b is slightly soluble (in water) and a very weakly acidic compound (based on its pKa). Crepidiaside b can be found in chicory and endive, which makes crepidiaside b a potential biomarker for the consumption of these food products.
[3aR-(3aR*,5E,9Z,11aR*)]- 2,3,3a,4,7,8,11,11a-Octahydro-6-methyl-3-methylene-2-oxo-, beta-D-glucopyranosyl ester cyclodeca[b]furan-10-carboxylic acid
[4R-(4R*,5S*,6S*,7S*,10R*,11E)]- 3-[(Acetyloxy)methyl]-5,6,7,8,9,10-hexahydro-6,7-dihydroxy-5,6,10-trimethyl-4-(1-oxopropoxy)-7,10-epoxycyclodeca[b]furan-2(4H)-one
9-(3-Hydroxy-3-methylglutaroyloxy)-abscisic acid|beta-hydroxy-beta-methylglutarylhydroxyabscisic acid
15-glucopyranosyloxy-2-oxo-guaia-3,11(13)-dien-1beta,5alpha,6beta,7alpha,10alphaH-12,6-olide
11,13alpha-dihydroixerin Z|11beta,13-dihydroixerin Z
11beta-hydroxyleucodin 11-O-beta-D-glucopyranoside|11beta-hydroxyleucodin-11-O-beta-glucopyranoside|11beta-hydroxyleucodin-O-beta-D-glucopyranoside|11beta-hydroxyleukodin 11-O-beta-glucopyranoside|11??-Hydroxyleukodin 11-O-??-glucopyranoside
beta-hydroxy-beta-methylglutaryl ester of 8-hydroxyabscisic acid
8beta,9alpha-dihydroxy-5alpha,9betaH-lindan-4(15),7(13)-dien-8alpha,12-olide-8beta-O-beta-D-glucopyranoside|chloranthalactone E 8-O-beta-D-glucopyranoside
3alpha-acetoxy-5beta-(4-acetoxytigloyloxy)-7-acetoxycarvotanacetone
(-)-(7R,8R)-4,7,9,8,9-pentahydroxy-3,3,5-trimethoxy-8-O-4-neolignan|3-(4-{[(1R,2R)-1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy}-3,5-dimethoxyphenyl)propane-1,2-diol|casearialignan D
2alpha-hydroperoxy-8-O-isobutyryl-9alpha-acetoxycumambrin B|2??-Hydroperoxy-8-O-isobutyryl-9??-acetoxycumambrin B
8alpha-(4-hydroxymethacryloyloxy)-10alpha-hydroxy-1,13-dimethoxy-hirsutinolide
(1R*,4R*,8S*,10R*)-1,4-epoxy-1-ethoxy-8,13-diacetoxy-10-hydroxy-germacra-5E,7(11)-dien-6,12-olide
O1-Me,8-propanoyl,13-Ac-1,4-Epoxy-1,8,10,13-tetrahydroxy-5,7(11)-germacradien-12,6-olide
C21H28O9_1-O-{[(3aS,6Z,10E,11aR)-10-Methyl-3-methylene-2-oxo-2,3,3a,4,5,8,9,11a-octahydrocyclodeca[b]furan-6-yl]carbonyl}-beta-D-glucopyranose
C21H28O9_2-Hydroxycyclohexyl 2-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-beta-D-glucopyranoside
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_major
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_7.2\\%
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_5.5\\%
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,6Z,10E,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate_4.0\\%
Ala Phe Gly Met
C19H28N4O5S (424.17803180000004)
Ala Phe Met Gly
C19H28N4O5S (424.17803180000004)
Ala Gly Phe Met
C19H28N4O5S (424.17803180000004)
Ala Gly Met Phe
C19H28N4O5S (424.17803180000004)
Ala Met Phe Gly
C19H28N4O5S (424.17803180000004)
Ala Met Gly Phe
C19H28N4O5S (424.17803180000004)
Cys Phe Gly Val
C19H28N4O5S (424.17803180000004)
Cys Phe Val Gly
C19H28N4O5S (424.17803180000004)
Cys Gly Phe Val
C19H28N4O5S (424.17803180000004)
Cys Gly Val Phe
C19H28N4O5S (424.17803180000004)
Cys Val Phe Gly
C19H28N4O5S (424.17803180000004)
Cys Val Gly Phe
C19H28N4O5S (424.17803180000004)
Asp Gly His Pro
C17H24N6O7 (424.17063939999997)
Asp Gly Pro His
C17H24N6O7 (424.17063939999997)
Asp His Gly Pro
C17H24N6O7 (424.17063939999997)
Asp His Pro Gly
C17H24N6O7 (424.17063939999997)
Asp Pro Gly His
C17H24N6O7 (424.17063939999997)
Asp Pro His Gly
C17H24N6O7 (424.17063939999997)
Phe Ala Gly Met
C19H28N4O5S (424.17803180000004)
Phe Ala Met Gly
C19H28N4O5S (424.17803180000004)
Phe Cys Gly Val
C19H28N4O5S (424.17803180000004)
Phe Cys Val Gly
C19H28N4O5S (424.17803180000004)
Phe Gly Ala Met
C19H28N4O5S (424.17803180000004)
Phe Gly Cys Val
C19H28N4O5S (424.17803180000004)
Phe Gly Met Ala
C19H28N4O5S (424.17803180000004)
Phe Gly Val Cys
C19H28N4O5S (424.17803180000004)
Phe Met Ala Gly
C19H28N4O5S (424.17803180000004)
Phe Met Gly Ala
C19H28N4O5S (424.17803180000004)
Phe Val Cys Gly
C19H28N4O5S (424.17803180000004)
Phe Val Gly Cys
C19H28N4O5S (424.17803180000004)
Gly Ala Phe Met
C19H28N4O5S (424.17803180000004)
Gly Ala Met Phe
C19H28N4O5S (424.17803180000004)
Gly Cys Phe Val
C19H28N4O5S (424.17803180000004)
Gly Cys Val Phe
C19H28N4O5S (424.17803180000004)
Gly Asp His Pro
C17H24N6O7 (424.17063939999997)
Gly Asp Pro His
C17H24N6O7 (424.17063939999997)
Gly Phe Ala Met
C19H28N4O5S (424.17803180000004)
Gly Phe Cys Val
C19H28N4O5S (424.17803180000004)
Gly Phe Met Ala
C19H28N4O5S (424.17803180000004)
Gly Phe Val Cys
C19H28N4O5S (424.17803180000004)
Gly His Asp Pro
C17H24N6O7 (424.17063939999997)
Gly His Pro Asp
C17H24N6O7 (424.17063939999997)
Gly Met Ala Phe
C19H28N4O5S (424.17803180000004)
Gly Met Phe Ala
C19H28N4O5S (424.17803180000004)
Gly Pro Asp His
C17H24N6O7 (424.17063939999997)
Gly Pro His Asp
C17H24N6O7 (424.17063939999997)
Gly Val Cys Phe
C19H28N4O5S (424.17803180000004)
Gly Val Phe Cys
C19H28N4O5S (424.17803180000004)
His Asp Gly Pro
C17H24N6O7 (424.17063939999997)
His Asp Pro Gly
C17H24N6O7 (424.17063939999997)
His Gly Asp Pro
C17H24N6O7 (424.17063939999997)
His Gly Pro Asp
C17H24N6O7 (424.17063939999997)
His Pro Asp Gly
C17H24N6O7 (424.17063939999997)
His Pro Gly Asp
C17H24N6O7 (424.17063939999997)
Met Ala Phe Gly
C19H28N4O5S (424.17803180000004)
Met Ala Gly Phe
C19H28N4O5S (424.17803180000004)
Met Phe Ala Gly
C19H28N4O5S (424.17803180000004)
Met Phe Gly Ala
C19H28N4O5S (424.17803180000004)
Met Gly Ala Phe
C19H28N4O5S (424.17803180000004)
Met Gly Phe Ala
C19H28N4O5S (424.17803180000004)
β-D-Glucopyranosiduronic acid, 2-(1H-indol-4-yloxy)-1-[[(1-methylethyl)amino]methyl]ethyl
Pro Asp Gly His
C17H24N6O7 (424.17063939999997)
Pro Asp His Gly
C17H24N6O7 (424.17063939999997)
Pro Gly Asp His
C17H24N6O7 (424.17063939999997)
Pro Gly His Asp
C17H24N6O7 (424.17063939999997)
Pro His Asp Gly
C17H24N6O7 (424.17063939999997)
Pro His Gly Asp
C17H24N6O7 (424.17063939999997)
Val Cys Phe Gly
C19H28N4O5S (424.17803180000004)
Val Cys Gly Phe
C19H28N4O5S (424.17803180000004)
Val Phe Cys Gly
C19H28N4O5S (424.17803180000004)
Val Phe Gly Cys
C19H28N4O5S (424.17803180000004)
Val Gly Cys Phe
C19H28N4O5S (424.17803180000004)
Val Gly Phe Cys
C19H28N4O5S (424.17803180000004)
Taraxinic acid glucosyl ester
N,N-Diacetylchitobiose
C16H28N2O11 (424.16930179999997)
The N,N-diacetylated derivative of chitobiose, but with no stereodesignation for the anomeric carbon atom. N,N'-Diacetylchitobiose is a dimer of β(1,4) linked N-acetyl-D glucosamine. N,N'-Diacetylchitobiose is the hydrolysate of chitin and can be used as alternative carbon source by?E. coli[1].
Anileridine hydrochloride
C22H30Cl2N2O2 (424.16842199999996)
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent
(3S,4S,5S)-3-amino-4,5-dihydroxy-6-[[(1S)-1-[(3S)-8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl]-3-methylbutyl]amino]-6-oxohexanoic acid
GlcNAc1-beta-3GalNAc
C16H28N2O11 (424.16930179999997)
beta-D-GlcpNAc-(1->6)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetyl-D-galactosamine having a N-acetyl-beta-D-glucosaminyl residue attached at the 6-position.
2-Acetamido-6-O-(2-acetamido-2-deoxy-a-D-galactopyranosyl)-2-deoxy-D-galactopyranose
C16H28N2O11 (424.16930179999997)
2-Acetamido-4-O-(2-acetamido-2-deoxy-a-D-galactopyranosyl)-2-deoxy-D-galactopyranose
C16H28N2O11 (424.16930179999997)
SPIRADOLINE
C22H30Cl2N2O2 (424.16842199999996)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics
12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one
C27H24N2O3 (424.17868339999995)
(4,11-Diacetyloxy-10-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl)methyl acetate
[(2R,4S,10R,11S)-10,11-diacetyloxy-4-hydroxy-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2-oxirane]-2-yl]methyl acetate
2-(3,4-dichlorophenyl)-N-methyl-N-[7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide
C22H30Cl2N2O2 (424.16842199999996)
beta-D-GalpNAc-(1->4)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->4)-D-GlcpNAc with beta configuration at the anomeric centre.
beta-D-GlcpNAc-(1->3)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprising an N-acetyl-beta-D-glucosamine residue linked (1->3) to an N-acetyl-beta-D-galactosamine residue at the reducing end.
beta-D-GlcpNAc-(1->6)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
beta-D-GlcpNAc-(1->6)-D-GalpNAc in which the anomeric configuration of the reducing-end GalNAc residue is alpha.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-alpha-D-glucosamine
C16H28N2O11 (424.16930179999997)
N-[1-(3-methoxyphenyl)-3-(1-naphthalenylamino)-3-oxopropyl]benzamide
C27H24N2O3 (424.17868339999995)
methyl 3-[[2-[4-(furan-2-carbonyl)piperazin-1-yl]acetyl]amino]-6-methyl-1H-indole-2-carboxylate
7-[[1-(2-oxolanylmethyl)-5-tetrazolyl]-(1-pyrrolidinyl)methyl]-5H-[1,3]dioxolo[4,5-g]quinolin-6-one
beta-D-GalpNAc-(1->3)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
2-Acetamido-6-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-2-deoxy-D-glucopyranose
C16H28N2O11 (424.16930179999997)
(2S,4R)-N-[(1S,2S)-2-chloro-1-[(3R,4S,5R,6R)-3,4,5-trihydroxy-6-(methylthio)-2-oxanyl]propyl]-1-methyl-4-propyl-2-pyrrolidinecarboxamide
C18H33ClN2O5S (424.17985980000003)
N-acetyl-D-galactosaminyl-(1->3)-N-acetyl-D-galactosamine
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->3)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprised of N-acetyl-alpha-D-galactosamine having an N-acetyl-D-galactosaminyl residue attached at the 3-position via a beta-linkage.
2-acetamido-4-O-(2-acetamido-2-deoxy-beta-D-galactopyranosyl)-2-deoxy-alpha-D-galactopyranose
C16H28N2O11 (424.16930179999997)
1,3-benzodioxol-5-yl-[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone
C27H24N2O3 (424.17868339999995)
N-[(2R,3S,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3R,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3R,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)oxan-3-yl]oxane-4-carboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2S,3S,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3S,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3R,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
[(1S,2aR,8bR)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(1R,2aR,8bR)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(3aS,4S,9bS)-1-(benzenesulfonyl)-5-methyl-8-pent-1-ynyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
C24H28N2O3S (424.18205380000006)
N-[(2S,3S,6R)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
N-[(2R,3R,6S)-6-[2-[(2-chlorophenyl)methylamino]-2-oxoethyl]-2-(hydroxymethyl)-3-oxanyl]-4-oxanecarboxamide
C21H29ClN2O5 (424.17648940000004)
[(1S,2aS,8bS)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
[(1R,2aS,8bS)-4-[(3-fluorophenyl)-oxomethyl]-1-(hydroxymethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-(4-oxanyl)methanone
2-acetamido-2-deoxy-D-gluco-hexopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galacto-hexopyranose
C16H28N2O11 (424.16930179999997)
[2-butyl-5-chloro-3-[[4-[2-(2,3-dihydro-1H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol
(3alpha)-3-Hydroxy-12,13-epoxytrichothec-9-ene-4,8,15-triyl triacetate
3-Hydroxy-12,13-epoxytrichothec-9-ene-4,8,15-triyl triacetate
[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3aS,10Z,11aR)-10-methyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-6-carboxylate
(2S,4R)-N-[(1R)-2-chloro-1-[(2R,3R,4S,5R,6S)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide
C18H33ClN2O5S (424.17985980000003)
platencin(1-)
C24H26NO6 (424.17600360000006)
A monocarboxylic acid anion that is the conjugate base of platencin resulting from the deprotonation of the carboxy group; major species at pH 7.3.
Cleocin
C18H33ClN2O5S (424.17985980000003)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors
beta-D-GalpNAc-(1->4)-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetylglucosamine having an N-acetylgalactosaminyl resiude attached at the 4-position via a beta-linkage.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-aldehydo-D-glucosamine
C16H28N2O11 (424.16930179999997)
alpha-D-GalpNAc-(1->4)-beta-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An alpha-D-GalpNAc-(1->4)-D-GlcpNAc in which the reducing end anomeric centre has beta-configuration.
D-GalpNAc-(1->3)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
A disaccharide composed of two 2-(acetylamino)-2-deoxy-D-galactopyranose units in (1->3) linkage.
2-Acetamido-2-deoxy-3-O-(2-acetamido-2-deoxy-B-D-glucopyranosyl)-D-galactopyranose
C16H28N2O11 (424.16930179999997)
beta-D-GalpNAc-(1->4)-alpha-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide comprised of N-acetyl-alpha-D-galactosamine having an N-acetyl-D-galactosaminyl residue attached at the 4-position via a beta-linkage. Important epitope forming part of the O-polysaccharides of some Gram-negative bacteria.
alpha-D-GalpNAc-(1->3)-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of two N-acetyl-D-galactosamine units joined via an alpha-(1->3)-linkage.
alpha-D-GalpNAc-(1->4)-D-GlcpNAc
C16H28N2O11 (424.16930179999997)
An amino disaccharide consisting of N-acetyl-D-glucosamine having an N-acetyl-alpha-D-galactosminyl resiude attached at the 4-position.
alpha-D-GalNpAc-(1->3)-beta-D-GalpNAc
C16H28N2O11 (424.16930179999997)
An alpha-D-GalpNAc-(1->3)-D-GalpNAc having beta-configuration at the reducing end anomeric centre.
clindamycin
C18H33ClN2O5S (424.17985980000003)
A carbohydrate-containing antibiotic that is the semisynthetic derivative of lincomycin, a natural antibiotic.
N-acetyl-beta-D-glucosaminyl-(1->4)-N-acetyl-beta-D-glucosamine
C16H28N2O11 (424.16930179999997)
An N,N-diacetylchitobiose having beta-configuration at the reducing end anomeric centre.
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3as,11ar)-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
5-hydroxy-3,6,9-trimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
[8-(acetyloxy)-11-ethoxy-10-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-6-yl]methyl acetate
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3ar,11as)-6-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-10-carboxylate
butyl (1s,3r,4r,5r)-1,3,4-trihydroxy-5-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
(2s,7s)-2-{[(1s)-1-{[(1s)-1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}ethyl]amino}-7-hydroxy-4-oxooctanoic acid
(1's,2s,2'r,3's,4z,5'r,7'r,8's,9'r,12's)-2'-hydroxy-12'-(2-hydroxypropan-2-yl)-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
4,5-dihydroxy-6-[(2-hydroxycyclohexyl)oxy]-2-(hydroxymethyl)oxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate
[(2r,3s,4s,5r,6r)-6-[(3z)-hex-3-en-1-yloxy]-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(3as,5r,9ar,9bs)-5-hydroxy-6-methyl-3-methylidene-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
5-(acetyloxy)-9-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(2s,4r)-n-{2-chloro-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid
C18H33ClN2O5S (424.17985980000003)
(3r,3ar,9as,9br)-3,6,9-trimethyl-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(1'r,2s,2's,3'r,4's,8'r,9'r)-9'-(acetyloxy)-12'-[(acetyloxy)methyl]-3'-(hydroxymethyl)-10'-oxaspiro[oxirane-2,7'-tricyclo[6.4.0.0²,⁴]dodecan]-11'-en-3'-ylmethyl acetate
(3ar,4s,9ar,9br)-4-hydroxy-6-methyl-3-methylidene-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,6h,6ah-azuleno[4,5-b]furan-2,7-dione
(3ar,4s,9as,9br)-4-hydroxy-6-methyl-3-methylidene-8-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,9h,9ah,9bh-azuleno[4,5-b]furan-2-one
(1's,2s,2'r,4's,7'r,9'r,10'r,11's)-4',11'-bis(acetyloxy)-10'-hydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6α)-form,beta-d-glucopyranosyl ester
{"Ingredient_id": "HBIN000219","Ingredient_name": "1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6\u03b1)-form,beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H28O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9727","PubChem_id": "NA","DrugBank_id": "NA"}
3,6,9-trimethyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(3as,5r,6ar,8s,9ar,9bs)-5-hydroxy-3,6,9-trimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(1s,5r,6r)-5-(acetyloxy)-3-[(acetyloxy)methyl]-6-isopropyl-2-oxocyclohex-3-en-1-yl (2e)-4-(acetyloxy)-2-methylbut-2-enoate
(3as,6s,6ar,9ar,9bs)-6-methyl-3-methylidene-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,6h,6ah,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
4-hydroxy-9-methyl-3,6-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
(1s,5r,6r)-5-(acetyloxy)-3-[(acetyloxy)methyl]-6-isopropyl-2-oxocyclohex-3-en-1-yl 4-(acetyloxy)-2-methylbut-2-enoate
(1r,14r)-9,15,15,24-tetramethyl-16-oxa-9,24-diazahexacyclo[12.12.0.0²,¹¹.0³,⁸.0¹⁷,²⁶.0¹⁸,²³]hexacosa-2(11),3,5,7,12,17(26),18,20,22-nonaene-10,25-dione
C27H24N2O3 (424.17868339999995)
methyl 6-(hepta-3,5-dien-1-yl)-2,4-dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]benzoate
10-hydroxy-11-methoxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-(hydroxymethyl)prop-2-enoate
(3ar,4s,6ar,8s,9ar,9br)-4-hydroxy-3,6,9-trimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(3as,11as)-3-methylidene-2-oxo-10-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
3-methylidene-2-oxo-10-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
(3ar,4r,6ar,9ar,9br)-4-hydroxy-9-methyl-3,6-dimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
[(1r,2e,8r,10s,11s)-8-(acetyloxy)-11-ethoxy-10-hydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-6-yl]methyl acetate
(1s,2s,4s,5s,6r,8s,10s)-8,10-diethoxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl 4-hydroxy-3-methoxybenzoate
(1r,9r,10r,12s,13r)-13-hydroxy-4,9-dimethyl-13-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-3,7-dien-5-one
(3ar,4s,6ar,9ar,9br)-4-hydroxy-9-methyl-3,6-dimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
4-hydroxy-3,6,9-trimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(3as,4r,5r,6s,6ar,8r,9bs)-5-(acetyloxy)-8-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(3as,5s,6ar,8s,9ar,9bs)-5-hydroxy-3,6,9-trimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3as,11as)-10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1s,9r,10r)-2,10-dimethyl-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-12-oxatricyclo[7.3.1.0¹,⁵]trideca-2,5-diene-4,11-dione
2'-hydroxy-12'-(2-hydroxypropan-2-yl)-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
(1s,2s,4s,5s,6r,8s,10r)-8,10-diethoxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl 4-hydroxy-3-methoxybenzoate
8-hydroxy-4,9-dimethyl-13-methylidene-7-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]tridec-3-en-5-one
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3as,11ar)-10-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
2-[(1-{[1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}ethyl)amino]-7-hydroxy-4-oxooctanoic acid
4-hydroxy-6-methyl-3-methylidene-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
(1s,2s,4s,5s,6r,8r,10r)-8,10-diethoxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl 4-hydroxy-3-methoxybenzoate
(3s,3as,9as,9bs)-3,6,9-trimethyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(3ar,4s,6ar,9ar,9bs)-4-hydroxy-9-methyl-3,6-dimethylidene-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
(3ar,4s,6ar,8s,9ar,9br)-4-hydroxy-3,6,9-trimethylidene-8-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(1r,9s,10r,12s,13s)-13-hydroxy-4,9-dimethyl-13-({[(2s,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-3,7-dien-5-one
(3as,4r,5r,6s,6as,7s,9ar,9br)-5-(acetyloxy)-7-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(2r,7s)-2-{[(1r)-1-{[(1r)-1-carboxy-2-(4-hydroxyphenyl)ethyl]-c-hydroxycarbonimidoyl}ethyl]amino}-7-hydroxy-4-oxooctanoic acid
3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
6,9-dimethyl-3-methylidene-5-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6h,6ah,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
4,5-dihydroxy-2-[(2-hydroxycyclohexyl)oxy]-6-(hydroxymethyl)oxan-3-yl 3-(4-hydroxyphenyl)prop-2-enoate
4-hydroxy-3-{[3-(2-hydroxyethyl)-1h-indol-2-yl](phenyl)methyl}-1-methylquinolin-2-one
C27H24N2O3 (424.17868339999995)
2-[4-(2,3-dihydroxypropyl)-2,6-dimethoxyphenoxy]-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3as,11as)-10-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
6-methyl-3-methylidene-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,6h,6ah,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(3ar,4r,6ar,8s,9ar,9br)-4-hydroxy-3,6,9-trimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(1's,2s,2'r,3's,4e,5'r,7'r,8's,9'r,12's)-2'-hydroxy-12'-(2-hydroxypropan-2-yl)-8'-methoxy-4-(1-methoxyethylidene)-7'-methyl-4',10'-dioxaspiro[oxolane-2,6'-tetracyclo[7.2.1.0²,⁷.0³,⁵]dodecane]-5,11'-dione
(3r)-8-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-6-hydroxy-3-{[(2r,6s)-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(1s,2s)-2-hydroxycyclohexyl]oxy}oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
butyl (1s,3r,4s,5r)-1,3,5-trihydroxy-4-{[(2e)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyl]oxy}cyclohexane-1-carboxylate
3-amino-4,5-dihydroxy-5-{[1-(8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl)-3-methylbutyl]-c-hydroxycarbonimidoyl}pentanoic acid
(3s,3ar,4s,9as,9br)-3,6,9-trimethyl-4-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-[(2-hydroxycyclohexyl)oxy]-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(3r)-6-{[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-{[(2r,6s)-6-methyloxan-2-yl]methyl}-3,4-dihydro-2-benzopyran-1-one
(3as,5r,6ar,8r,9ar,9bs)-5-hydroxy-3,6,9-trimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
6-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-8-hydroxy-3-[(6-methyloxan-2-yl)methyl]-3,4-dihydro-2-benzopyran-1-one
(3as,5r,6ar,8s,9ar,9bs)-5-hydroxy-3,6,9-trimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
9,15,15,24-tetramethyl-16-oxa-9,24-diazahexacyclo[12.12.0.0²,¹¹.0³,⁸.0¹⁷,²⁶.0¹⁸,²³]hexacosa-2(11),3,5,7,12,17(26),18,20,22-nonaene-10,25-dione
C27H24N2O3 (424.17868339999995)
(3r,4r,5r)-3-amino-4,5-dihydroxy-5-{[(1s)-1-[(3r)-8-hydroxy-1-oxo-3,4-dihydro-2-benzopyran-3-yl]-3-methylbutyl]-c-hydroxycarbonimidoyl}pentanoic acid
(1's,2r,2'r,4's,7'r,9'r,10'r,11's)-4',11'-bis(acetyloxy)-10'-hydroxy-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl acetate
(3ar,4r,5r,6s,6ar,8r,9bs)-5-(acetyloxy)-8-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,8h,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
(3as,5r,6r,6as,9ar,9bs)-6,9-dimethyl-3-methylidene-5-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6h,6ah,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
3,6,9-trimethyl-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
6-[(acetyloxy)methyl]-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-methylpropanoate
8,10-diethoxy-2-(hydroxymethyl)-3,9-dioxatricyclo[4.4.0.0²,⁴]decan-5-yl 4-hydroxy-3-methoxybenzoate
(3ar,4r,5r,6s,6as,9s,9as,9br)-5-(acetyloxy)-9-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 6-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,11h,11ah-cyclodeca[b]furan-10-carboxylate
(1r,2e,8s,10r,11s)-10-hydroxy-11-methoxy-6-(methoxymethyl)-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.0³,⁷]tetradeca-2,6-dien-8-yl 2-(hydroxymethyl)prop-2-enoate
n-[(3r,4r,5s,6r)-5-{[(2s,3r,4r,5s,6r)-4,5-dihydroxy-3-[(1-hydroxyethylidene)amino]-6-(hydroxymethyl)oxan-2-yl]oxy}-2,4-dihydroxy-6-(hydroxymethyl)oxan-3-yl]ethanimidic acid
C16H28N2O11 (424.16930179999997)
(2r,3r,4s,5s,6r)-4,5-dihydroxy-2-{[(1s,2r)-2-hydroxycyclohexyl]oxy}-6-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(3as,6s,6as,9ar,9bs)-6-methyl-3-methylidene-9-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,6h,6ah,9ah,9bh-azuleno[4,5-b]furan-2,7-dione
5-(acetyloxy)-7-hydroperoxy-6-hydroxy-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-methylpropanoate
13-hydroxy-4,9-dimethyl-13-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-6-oxatetracyclo[7.4.0.0³,⁷.0¹⁰,¹²]trideca-3,7-dien-5-one
5-hydroxy-6-methyl-3-methylidene-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-methyl-3-methylidene-2-oxo-3ah,4h,7h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-{[(1s,2s)-2-hydroxycyclohexyl]oxy}oxan-2-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate
(1r,2r)-2-{4-[(2s)-2,3-dihydroxypropyl]-2,6-dimethoxyphenoxy}-1-(4-hydroxy-3-methoxyphenyl)propane-1,3-diol
n-{2-chloro-1-[3,4,5-trihydroxy-6-(methylsulfanyl)oxan-2-yl]propyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid
C18H33ClN2O5S (424.17985980000003)